Chemoinformaics analysis of Malvidin 3-rutinoside-5-glucoside
| Molecular Weight | 801.724 | nRot | 11 |
| Heavy Atom Molecular Weight | 756.364 | nRig | 35 |
| Exact Molecular Weight | 801.245 | nRing | 6 |
| Solubility: LogS | -1.92 | nHRing | 4 |
| Solubility: LogP | -0.757 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 101 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 56 | No. of Aromatic Carbocycles | 2 |
| nHetero | 21 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 45 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 21 | No. of Arom Bond | 17 |
| nHA | 20 | APOL | 105.298 |
| nHD | 12 | BPOL | 60.7683 |
| QED | 0.086 |
| Synth | 5.571 |
| Natural Product Likeliness | 1.581 |
| NR-PPAR-gamma | 0.647 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.996 |
| HIA | 0.947 |
| CACO-2 | -6.585 |
| MDCK | 0.00010812 |
| BBB | 0.27 |
| PPB | 0.599058 |
| VDSS | 0.563 |
| FU | 0.344774 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.051 |
| CYP2c19-inh | 0.004 |
| CYP2c19-sub | 0.092 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.082 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.15 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.001 |
| CL | 0.891 |
| T12 | 0.623 |
| hERG | 0.251 |
| Ames | 0.161 |
| ROA | 0.014 |
| SkinSen | 0.024 |
| Carcinogencity | 0.053 |
| EI | 0.006 |
| Respiratory | 0.007 |
| NR-Aromatase | 0.75 |
| Antiviral | Yes |
| Prediction | 0.759404 |